Dexamethasone Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Safety and Efficacy of DSM 32444 Postbiotic in the Treatment of Acute Rhinosinusitis
Conditions:   Rhinosinusitis;   Rhinitis Interventions:   Drug: Dexamethasone/Neomycin;   Combination Product: Bacillus subtilis DSM32444, inactivated Sponsors:   Huro Biotech Joint Stock Company;   Vietstar Biomedical Research Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials